Midatech Pharma: Edison Open House Healthcare 2022

Published on 9 February 2022

Midatech Pharma is a drug-delivery specialist focused on re-engineering therapeutics through its technology platforms (MidaSolve – local drug-delivery, Qsphera – sustained-release, MidaCore – targeted delivery) to improve their bioavailability and delivery.

• Tell us about your drug delivery technology and why it’s necessary?
• How are your three different technology platforms: Q-Sphera, MidaSolve and MidaCore different from other drug delivery solutions?
• What advantages does Midatech offer over others in this space?
• What is the pipeline for Q-Sphera?
• How can your technology be used to enhance existing medicines?
• What can you tell us about your other key programme, MTX110?
• What are your commercialisation plans for MTX110?
• Which milestones should investors focus on in the coming year?
• How do you see the opportunities for partnerships and licensing opportunities developing?
• What does your cash runway look like?

Share this with friends and colleagues